Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Beschreibung
"Transcranial magnetic stimulation (TMS) is a noninvasive method to stimulate the human brain, modulating brain activity without surgery or anesthesia. TMS uses a brief, high-intensity, pulsed magnetic field, which induces an electrical field capable of depolarizing a localized brain area. In October 2008, the first TMS system was cleared by the FDA to treat adult patients with major depressive disorder (MDD) who have not responded to one antidepressant medication. Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice, 2nd Edition, is a practical reference for managing patients who are candidates for TMS. Since publication of the first edition, devices have received FDA clearance for obsessive-compulsive disorder, anxiety comorbid with MDD, and smoking cessation, and insurance coverage for TMS has expanded. The book discusses the integration of TMS with psychotherapy, pharmacotherapy, and other forms of neuromodulation; the identification of appropriate patients for referral to a TMS clinician; coordination of care to ensure the best outcomes during the acute, continuation, and maintenance treatment phases of depression; and the evolving nature of TMS research. The volume appendix lists various options for advanced TMS training"--
"Transcranial magnetic stimulation (TMS) is a noninvasive method to stimulate the human brain, modulating brain activity without surgery or anesthesia. TMS uses a brief, high-intensity, pulsed magnetic field, which induces an electrical field capable of depolarizing a localized brain area. In October 2008, the first TMS system was cleared by the FDA to treat adult patients with major depressive disorder (MDD) who have not responded to one antidepressant medication. Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice, 2nd Edition, is a practical reference for managing patients who are candidates for TMS. Since publication of the first edition, devices have received FDA clearance for obsessive-compulsive disorder, anxiety comorbid with MDD, and smoking cessation, and insurance coverage for TMS has expanded. The book discusses the integration of TMS with psychotherapy, pharmacotherapy, and other forms of neuromodulation; the identification of appropriate patients for referral to a TMS clinician; coordination of care to ensure the best outcomes during the acute, continuation, and maintenance treatment phases of depression; and the evolving nature of TMS research. The volume appendix lists various options for advanced TMS training"--
Details
Erscheinungsjahr: 2025
Fachbereich: Andere Fachgebiete
Genre: Importe, Medizin
Rubrik: Wissenschaften
Medium: Taschenbuch
Inhalt: Einband - flex.(Paperback)
ISBN-13: 9798894550657
Sprache: Englisch
Einband: Kartoniert / Broschiert
Autor: Richard A. Bermudes
Karl Lanocha
Philip G. Janicak
Redaktion: Lanocha, Karl
Janicak, Philip G.
Bermudes, Richard A.
Auflage: Second Edition
Hersteller: American Psychiatric Association Publishing
Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 234 x 153 x 21 mm
Von/Mit: Karl Lanocha (u. a.)
Erscheinungsdatum: 28.02.2025
Gewicht: 0,542 kg
Artikel-ID: 132533878

Ähnliche Produkte

Taschenbuch